Sulfonamides for Treatment of Endothelin-mediated Disorders

Details for Australian Patent Application No. 2002301228 (hide)

Owner Texas Biotechnology Corporation

Inventors Wu, Chengde; Keller, Karin; Kogan, Timothy; Woodard, Patricia; Blok, Natalie

Agent Spruson & Ferguson

Pub. Number AU-A-2002301228

Parent 69504

Filing date 20 September 2002

Wipo publication date 27 February 2003

International Classifications

C07D 413/12 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

A61K 031/42 - Oxazoles

Event Publications

27 February 2003 Application Open to Public Inspection

  Published as AU-A-2002301228

3 July 2003 Change of Name(s) of Applicant(s), Section 104

  Texas Biotechnology Corporation The name of the applicant has been changed to Encysive Pharmaceuticals, Inc.

27 October 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002301229-Synthetic Antigens for CD1-restricted Immune Responses

2002301227-Nanomolar, Non-peptide Inhibitors of Cathepsin D